DEFA14A: Trevi Therapeutics Sets Date for Annual Stockholders Meeting, Seeks Director Elections and Auditor Ratification

Trevi Therapeutics is holding its annual meeting of stockholders on June 13, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its auditor.

Summary

• Trevi Therapeutics, Inc. is soliciting proxies for its Annual Meeting of Stockholders to be held on June 13, 2024.
• The meeting will take place at 12:30 p.m. Eastern Time.
• Stockholders of record as of April 15, 2024, are eligible to vote.
• The board of directors recommends voting for the election of three Class II directors and for the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The three Class II director nominees are Dominick Colangelo, Edward Mathers, and David Meeker, M.D.
• Stockholders can vote online, by phone, or by mail.
• To attend the meeting online and/or participate, stockholders must register by June 12, 2024, at 5:00 p.m. Eastern Time.

Sentiment

Score: 5

Explanation: The document is a routine proxy statement, so the sentiment is neutral.

Positives

• The proxy statement provides clear instructions for stockholders to vote.
• The board of directors has made recommendations on how to vote on each proposal.

Industry Context

This is a standard proxy statement for an annual meeting, a routine part of corporate governance.

Stakeholder Impact

• Shareholders are asked to vote on key corporate governance matters.
• The outcome of the votes will influence the composition of the board and the selection of the company's auditor.

Next Steps

• Stockholders should review the proxy statement and vote on the proposals.
• Stockholders who wish to attend the meeting online should register by the specified deadline.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Auditor, Trevi Therapeutics, Voting